Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Risk for Developing Breast Cancer”

19 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 19 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07492121
What this trial is testing

Screening for Brain Metastases

Who this might be right for
Lung Cancer Stage IVMelanoma Stage IVBreast Cancer Metastatic
University of Zurich 180
Not applicableActive Not RecruitingNCT02494869
What this trial is testing

Dose-Response of Aerobic Training in Women at High-Risk for Development of Breast Cancer

Who this might be right for
High Risk for Developing Breast Cancer
Memorial Sloan Kettering Cancer Center 75
Not applicableStudy completedNCT00255060
What this trial is testing

Comprehensive Screening for Women at High Genetic Risk for Developing Breast Cancer

Who this might be right for
Breast Cancer
Stanford University 100
Very early researchEnded earlyNCT01292733
What this trial is testing

Cancer Screening Program for Women at High Risk for Developing Ovarian Cancer

Who this might be right for
Ovarian DiseasesOvarian Neoplasms
Swedish Medical Center 534
Not applicableUnknownNCT00407706
What this trial is testing

Using Test of SCM for Detection Breast Cancer

Who this might be right for
Malignant Breast Cancer, Benign Breast Lesions
Ziv Hospital 180
Not applicableWithdrawnNCT03261323
What this trial is testing

Breast Reconstruction Following Breast Cancer in Very High Risk Patients

Who this might be right for
Breast CancerMalignant Neoplasm of Breast
Case Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00291694
What this trial is testing

Protocol for Women at Increased Risk of Developing Breast Cancer

Who this might be right for
Breast Cancer
Carol Fabian, MD 72
Testing effectiveness (Phase 2)Study completedNCT00019500
What this trial is testing

Raloxifene in Preventing Breast Cancer in Premenopausal Women

Who this might be right for
Breast Cancer
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00001378
What this trial is testing

A Pilot Trial of Tamoxifen and 4-HPR (4-N-Hydroxyphenyl Retinamide) in Persons at High Risk for Developing Breast Cancer

Who this might be right for
Breast CancerBreast Neoplasms
National Cancer Institute (NCI) 75
Testing effectiveness (Phase 2)Study completedNCT00291135
What this trial is testing

Protocol for Women at Increased Risk of Developing Breast Cancer

Who this might be right for
Breast Cancer
Carol Fabian, MD 42
Not applicableStudy completedNCT00291083
What this trial is testing

Protocol for Postmenopausal Women at Increased Risk of Developing Breast Cancer

Who this might be right for
Breast Cancer
Carol Fabian, MD 229
Large-scale testing (Phase 3)Active Not RecruitingNCT05587296
What this trial is testing

Learn More About How Well Elinzanetant Works and How Safe it is Compared to Placebo for the Treatment of Hot Flashes Caused by Anti-cancer Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer

Who this might be right for
Vasomotor Symptoms Caused by Adjuvant Endocrine Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast CancerHot Flashes
Bayer 474
Not applicableLooking for participantsNCT00291096
What this trial is testing

High Risk Breast Clinic: Protocol for Women at Increased Risk for Developing Breast Cancer

Who this might be right for
Breast Cancer
Carol Fabian, MD 3,000
Not applicableWithdrawnNCT00083044
What this trial is testing

Ductal Lavage in Assessing Women With Early Breast Cancer or at High Risk of Developing Breast Cancer and Who Are Eligible For Tamoxifen Therapy

Who this might be right for
Breast Cancer
Northwestern University
Not applicableWithdrawnNCT00329017
What this trial is testing

Protocol for Postmenopausal Women at Increased Risk of Developing Breast Cancer

Who this might be right for
Breast Cancer
Carol Fabian, MD
Early research (Phase 1)Study completedNCT01282580
What this trial is testing

Dietary Fish and Omega 3 Fatty Acids for Breast Cancer Prevention

Who this might be right for
Breast Cancer
Ohio State University Comprehensive Cancer Center 25
Not applicableStudy completedNCT00001837
What this trial is testing

Effects of Raloxifene on the Uterus and Ovaries of Premenopausal Patients

Who this might be right for
Breast CancerBreast Neoplasm
National Institutes of Health Clinical Center (CC) 60
Not applicableStudy completedNCT00084669
What this trial is testing

Venlafaxine With or Without Zolpidem in Treating Hot Flashes and Associated Sleep Disorders in Women With Breast Cancer OR at High Risk for Developing Breast Cancer

Who this might be right for
Breast CancerHot FlashesSleep Disorders
Massachusetts General Hospital 119
Not applicableStudy completedNCT00003736
What this trial is testing

MRI for Detecting Cancer in Women Who Are at High Risk of Developing Breast Cancer

Who this might be right for
Breast Cancer
Abramson Cancer Center at Penn Medicine 200